Health Care/Hospital

deCODE genetics: Monozygous but not identical

By sequencing the germline genomes of twins and comparing them to those of close relatives, scientists at deCODE genetics found mutations that are present in just one of themonozygotic twins and traced them back to the first days after conception. REYKJAVIK, Iceland, Jan. 8, 2021 /PRNewswire/ --...

2021-01-08 00:00 2659

First patient in treatment in RhoVac's clinical phase IIb study in United Kingdom

STOCKHOLM, Jan. 7, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, on January 7th, 2021, that the first patient in United Kingdom is enrolled in the company's clinical phase IIb study in prostate cancer, a study named RhoVac-002 ("BRaVac"). The first patient in United Kingdom is enroll...

2021-01-07 22:40 1848

Inteleos and APA Partner to Offer Free Mental Health Resources to All Healthcare Professionals

Participation includes complimentary AMA PRA Category 1 CME Credit™  ROCKVILLE, Maryland. and WASHINGTON, Jan. 7, 2021 /PRNewswire/ -- Inteleos, a non-profit global healthcare certification organization, and theAmerican Psychological Association (APA), the leading scientific and professional or...

2021-01-07 22:02 1829

Caprion-HistoGeneX Acquires Clinical Logistics Inc., a Virtual Central Specimen Management CRO, and Expands its Support of Clinical Trials Specimen Logistics

MONTREAL, Jan. 7, 2021 /PRNewswire/ -- Caprion-HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners, announced today the acquisition of Clinical Logistics Inc. ("CLI"), a Virtual Central Specimen Management CRO based inHalifax, Canada. The...

2021-01-07 21:20 2051

Medical Waste Management Inherits a Multi-billion Dollar Opportunity from the Ongoing Pandemic

Asia-Pacific presents immense growth opportunities for medical waste management market participants as regulations mature and are thoroughly enforced, says Frost & Sullivan SANTA CLARA, Calif., Jan. 7, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis,Growth Opportunities in the Medical Wa...

2021-01-07 21:10 1948

Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies

CAMBRIDGE, Mass. and SUZHOU, China, Jan. 7, 2021 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced the first closing of an oversubscribed$53.5 million Series B+ fina...

2021-01-07 20:31 2398

IACTA Pharmaceuticals and Pharmaleads to Develop the World's First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain

- Ocular Pain, a $10+ billion global market, with significant unmet medical need - License agreement aims to accelerate global development of DENKIs, leveraging expertise and resources of both companies IRVINE, California, PARIS, HONG KONG, Jan. 7, 2021 /PRNewswire/ -- IACTA Pharmaceuticals, Inc...

2021-01-07 20:00 2102

Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics

- Adds to Merck's lipid manufacturing expertise, providing an integrated offering across mRNA value chain - AmpTec's differentiated polymerase chain reaction (PCR)-based technology has shown to have advantages over other technologies for mRNA manufacturing - Diagnostics business focused on produ...

2021-01-07 17:00 3807

Qiming Venture Partners' Portfolio Company APT Medical Listed on STAR Board of Shanghai Stock Exchange

SHANGHAI, Jan. 7, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company APT Medical (SHSE: 688617) today successfully listed on the Science and Technology Innovation Board (the STAR Board) of Shanghai Stock Exchange. The issue price isCNY 74.46 per share. The stock opened at CNY 221.73 ...

2021-01-07 16:13 3193

GEN inCode Appoints New Chairman

OXFORD, England, Jan. 7, 2021 /PRNewswire/ -- GEN inCode UK Limitedthe privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, announces today the appointment of Bill Rhodes as non-executive Chairman of the Company, effective 1 Ja...

2021-01-07 15:00 5320

New Thai health drink 'QminC' surges during COVID-19 pandemic

BANGKOK, Jan. 7, 2021 /PRNewswire/ -- Four months after its launch in Thailand , an innovative health drink fortified with curcumin extracted from the turmeric plant's rootstalks, has found its way on to the shelves of more than 15,000 modern trade retail outlets and almost 500,000 mom and pop s...

2021-01-07 11:31 6416

CGTN: What drives China's success in 2020

BEIJING, Jan. 6, 2021 /PRNewswire/ -- Facing unprecedented challenges brought by COVID-19 and the complex changes in external environment, the Communist Party ofChina (CPC) Central Committee with Comrade Xi Jinping at the core has ledChina to achieve substantial progress in 2020. &nb...

2021-01-06 23:16 3296

Everest Medicines Announces CTA Approval by China NMPA for Phase 3 Trial of Sacituzumab Govitecan-Hziy for Metastatic Urothelial Cancer

SHANGHAI, Jan. 6, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, today announced th...

2021-01-06 21:54 5732

Everest Medicines Initiates Submission of New Drug Application in Singapore for Sacituzumab Govitecan-Hziy for the Treatment of Metastatic Triple-Negative Breast Cancer

SHANGHAI, Jan. 6, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, announced today th...

2021-01-06 21:52 5930

INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Vulvar Dysplasia Caused by HPV-16/18

- DNA immunotherapy candidate VGX-3100 demonstrated clinically significant reduction of HPV-16/18-associated precancerous vulvar lesions in 63% of treated participants six months after treatment - Phase 2 results indicate that VGX-3100 can be a safe, tolerable and efficacious adjunct to current ...

2021-01-06 21:00 3417

RedHill Biopharma's RHB-204 Granted FDA Fast Track Designation for NTM Disease

TEL AVIV, Israel and RALEIGH, NC, Jan. 6, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or "the Company"), a specialty biopharmaceutical company, today announced that RHB-204 has been granted Fast Track designation by the U.S. Food and...

2021-01-06 20:24 5402

Eleva Secures up to EUR 60 million to Advance a Drug Candidate, Appoints New Board Member

FREIBURG, Germany, Jan. 6, 2021 /PRNewswire/ -- Eleva, a manufacturer of superior biologics, has secured up toEUR 60 million in funding from Zukunftsfonds Heilbronn (ZFHN). The funds will help advance one of its drug candidates, CPV-101, to stages that will facilitate further investment from ven...

2021-01-06 17:00 1658

Yiling Pharma expects to double its YoY net profit in 2020

SHIJIAZHUANG, China, Jan. 6, 2021 /PRNewswire/ -- Yiling Pharmaceutical, a Shenzhen stock market listed enterprise (002603.SZ), has recently published its 2020 earnings projection. The yearly net profit belonging to its shareholders is anticipated to be between 1.152 billion Chinese yuan and 1.27...

2021-01-06 16:55 6376

JOYSBIO's COVID-19 antigen test kit is capable of detecting the new SARS-COV-2 strain found in the United Kingdom and the United States

BINHAI, Tianjin, Jan. 6, 2021 /PRNewswire/ -- As the world watches a concerning new strain of SARS-COV-2 first identified in theUnited Kingdom, one global biotech company has announced that their antigen test kit can detect the variant. JOYSBIO Biotechnology Co.'s SARS-CoV-2 Antigen Rapid Test K...

2021-01-06 15:11 2192

Dr Ivan Puah Predicts 2021 To Be A Year Of Evolving Cosmetic Surgery & Lifestyle Changes In Singapore In The COVID-19 Era

SINGAPORE, Jan. 6, 2021 /PRNewswire/ -- It's been a year since COVID-19 disrupted lives and livelihoods. Prime Minister ofSingapore, Mr. Lee Hsien Loong, has recently announced that Singaporeans can expect the vaccines to be made available in early 2021. This good news brings much relief to th...

2021-01-06 14:27 1698
1 ... 383384385386387388389 ... 554